These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 163165

  • 1. Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.
    Elkeles RS, Lazarus JH, Siddle K, Campbell AK.
    Clin Sci Mol Med; 1975 Jan; 48(1):27-31. PubMed ID: 163165
    [Abstract] [Full Text] [Related]

  • 2. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
    Paisey R, Elkeles RS, Hambley J, Belchetz PE.
    Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
    [Abstract] [Full Text] [Related]

  • 3. Thyroid function and plasma cyclic AMP response to intravenous glucagon.
    Madsen SN.
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):760-8. PubMed ID: 196468
    [Abstract] [Full Text] [Related]

  • 4. Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.
    Mac Neil S, Hendy GN, Amirrasooli H, Daggett PR, Tomlinson S.
    J Endocrinol Invest; 1980 Aug; 3(4):401-4. PubMed ID: 6259251
    [Abstract] [Full Text] [Related]

  • 5. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)].
    Jäckel W, Heimes J, Herrmann J.
    J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272
    [Abstract] [Full Text] [Related]

  • 6. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment.
    Kautzky-Willer A, Ludwig C, Nowotny P, Roden A, Huemer C, Widhalm K, Vierhapper H, Waldhäusl W, Roden M.
    Eur J Clin Invest; 1999 May; 29(5):395-403. PubMed ID: 10354196
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proceedings: Plasma cyclic AMP response to glucagon in thyroid disease.
    Elkeles RS, Siddle K, Lazarus JH, Campbell AK, Addison GM.
    Clin Sci Mol Med; 1974 Sep; 47(3):14P-15P. PubMed ID: 4370892
    [No Abstract] [Full Text] [Related]

  • 9. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
    Ahrén B, Lundquist I, Hedner P, Valdemarsson S, Scherstén B.
    Diabetes Res; 1985 Mar; 2(2):95-103. PubMed ID: 2412749
    [Abstract] [Full Text] [Related]

  • 10. Influence of somatostatin on plasma cyclic AMP and metabolic substrate responses to i.v. adrenaline and glucagon in humans.
    Nistrup Madsen S, Christensen SE, Hansen AP, Thode J.
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):431-7. PubMed ID: 6120054
    [Abstract] [Full Text] [Related]

  • 11. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN, Tomlinson S, O'Riordan JL.
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [Abstract] [Full Text] [Related]

  • 12. Plasma cyclic nucleotide responses to insulin-induced hypoglycaemia and methacholine in patients with hyperthyroidism.
    Okada F, Ide H, Hata S, Honma M, Ui M.
    Eur J Clin Invest; 1980 Feb; 10(1):81-6. PubMed ID: 6245892
    [Abstract] [Full Text] [Related]

  • 13. Plasma cyclic nucleotide levels in hyperthyroidism.
    Lin T.
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):62-8. PubMed ID: 216209
    [Abstract] [Full Text] [Related]

  • 14. Development of ketonemia in fasting patients with hyperthyroidism.
    Bartels PD, Kristensen LO, Heding LG, Sestoft L.
    Acta Med Scand Suppl; 1979 Jan; 624():43-7. PubMed ID: 284713
    [Abstract] [Full Text] [Related]

  • 15. Changes in plasma glucose, insulin (IRI), glucagon (IRG) and free fatty acids (FFA) following alanine loading in hyperthyroid patients.
    Ida H, Yamamoto T, Ninomiya H, Sasaki H, Asano T, Okumura M.
    Endocrinol Jpn; 1987 Dec; 34(6):937-45. PubMed ID: 3330025
    [Abstract] [Full Text] [Related]

  • 16. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans.
    Søvik O, Heiervang E, Aksnes L, Selvig S.
    Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266
    [Abstract] [Full Text] [Related]

  • 17. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
    Vlachoyannis J, Schoeppe W.
    Klin Wochenschr; 1982 Jul 01; 60(13):651-7. PubMed ID: 6289001
    [Abstract] [Full Text] [Related]

  • 18. Plasma somatostatin is elevated in primary hypothyroidism compared with hyperthyroidism.
    Skare S, Hanssen KF, Norman N.
    Acta Endocrinol (Copenh); 1986 Mar 01; 111(3):331-5. PubMed ID: 2870598
    [Abstract] [Full Text] [Related]

  • 19. The relationship between thyroid function and the renal response to parathyroid hormone.
    Ashby JP, MacPherson JN, Strong JA.
    Clin Endocrinol (Oxf); 1977 Aug 01; 7(2):167-70. PubMed ID: 196793
    [Abstract] [Full Text] [Related]

  • 20. Cyclic AMP infusion and blood sugar, serum insulin and serum nonesterified fatty acid responses to glucose in recent experimental hyperthyroid dogs.
    Renauld A, Garrido D.
    Acta Physiol Pharmacol Ther Latinoam; 1992 Aug 01; 42(4):255-76. PubMed ID: 1343982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.